Clinical trials
Phase 3 Fibrosis trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 2 |
| 2009 | 2 |
| 2012 | 2 |
| 2014 | 3 |
| 2015 | 2 |
| 2016 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Active, not recruiting | 2 |
| Recruiting | 2 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gilead Sciences | 3 |
| 89bio, Inc. | 2 |
| Vertex Pharmaceuticals Incorporated | 2 |
| AbbVie | 1 |
| Bristol-Myers Squibb | 1 |
| Genfit | 1 |
| Intercept Pharmaceuticals | 1 |
| Inventiva Pharma | 1 |
| Janssen-Cilag International NV | 1 |
| Novartis Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fibrosis | 17 |
| Hepatitis C | 5 |
| Non-alcoholic Fatty Liver Disease | 4 |
| Digestive System Diseases | 3 |
| Liver Diseases | 3 |
| Cystic Fibrosis | 2 |
| Fatty Liver | 2 |
| Genetic Diseases, Inborn | 2 |
| Hepatitis C, Chronic | 2 |
| Infant, Newborn, Diseases | 2 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.